Hear from real healthcare professionals and their patients about how the use of Glucerna
helped to support the management of their blood glucose levels.
Stabilising Blood Glucose Levels to Minimise Occurrence of Hypoglycaemic Episodes
Featuring Trish (the patient), Geraldine Georgeou (the dietitian) and Dr Sneha Wadhwani (the GP).
Trish is living with Type 2 Diabetes, has been on oral hypoglycaemic medications and has been following a dietitian-recommended diet, but has been experiencing hypoglycaemic episodes throughout the night.
Watch this case study to see how Glucerna helped cease Trish’s overnight hypoglycaemic episodes & reduce her blood glucose and HbA1c levels.
63 years old, diagnosed with type 2 diabetes mellitus (T2DM).
Medications: oral hypoglycaemics.
Following a dietitian-recommended diet.
Experiencing hypoglycaemic episodes throughout the night.
Commenced Glucerna as a night-time snack to stabilise blood glucose levels.
Results
Hypoglycaemic episodes ceased.
-2.4 mmol/L reduction in fasting blood glucose levels to 4.4 mmol/L.
-1.1% reduction in HbA1c to 5.4%.
CONCLUSION
“Products like Glucerna can be really helpful in this space to give us an even spread of glycaemic control throughout the day and night, so that patients don’t experience such swings in their glycaemia.”
Dr Sneha Wadhwani
Managing Blood Glucose and Nourishing the Body While Using Semaglutide (e.g. Ozempic®, Wegovy® or Rybelsus®)
Featuring Joan (the patient), Geraldine Georgeou (the dietitian) and Dr Sneha Wadhwani (the GP)
Joan has been diagnosed with impaired glucose tolerance and is taking Semaglutide and Metformin to address her body weight of 126 kg. Joan experienced a suppressed appetite resulting in low energy/lethargy.
Watch this case study to see how Joan used Glucerna to provide balanced nutrition (improving her energy levels and enabling her to recommence activities) while helping manage her blood glucose and weight.
63 years old, diagnosed with impaired glucose tolerance.
Body weight of 126 kg.
Medications: Metformin and Semaglutide.
Appetite suppressed by semaglutide resulting in low energy/lethargy.
Glucerna for lunch and dinner to provide balanced nutrition, while helping manage blood glucose levels and weight.
Results
-1.5 mmol/L reduction in fasting blood glucose levels to 5.1 mmol/L.
-20 kg body weight reduction.
More energy with ability to recommence activities.
CONCLUSION
“Patients engaged in their weight management journey can be focused on the short-term weight goal at the expense of micro-nutrient nutrition that can affect lean body mass and manifest as weakness and low energy. Glucerna is designed as a long-lasting fuel to nourish, while helping to regulate blood glucose levels.”
Geraldine Georgeou
Food for Special Medical Purposes. Use only under medical supervision.
ANZ.2025.57573.GLU.1 (v1.0)
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
Do you wish to continue and exit this website?
.png)
ANZ.2024.53720.ENS -GLU -PDS.1 (v1.0)
Stay Connected